Robert V. Rawson

2.6k total citations
49 papers, 599 citations indexed

About

Robert V. Rawson is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Robert V. Rawson has authored 49 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 23 papers in Molecular Biology and 10 papers in Immunology. Recurrent topics in Robert V. Rawson's work include Cutaneous Melanoma Detection and Management (31 papers), Melanoma and MAPK Pathways (20 papers) and CAR-T cell therapy research (11 papers). Robert V. Rawson is often cited by papers focused on Cutaneous Melanoma Detection and Management (31 papers), Melanoma and MAPK Pathways (20 papers) and CAR-T cell therapy research (11 papers). Robert V. Rawson collaborates with scholars based in Australia, United States and Netherlands. Robert V. Rawson's co-authors include Richard A. Scolyer, John F. Thompson, Georgina V. Long, James S. Wilmott, Peter M. Ferguson, Víctor G. Prieto, Jeffrey E. Gershenwald, Serigne Lo, Robyn P.M. Saw and Alexander M. Menzies and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Robert V. Rawson

45 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert V. Rawson Australia	14	461	200	155	71	64	49	599
Nicole de Rosa United States	10	379 0.8×	135 0.7×	156 1.0×	129 1.8×	48 0.8×	15	541
Mariana Petaccia de Macêdo Brazil	15	395 0.9×	135 0.7×	105 0.7×	90 1.3×	120 1.9×	69	636
Mari F.C.M. van den Hout Netherlands	13	441 1.0×	162 0.8×	281 1.8×	81 1.1×	48 0.8×	29	644
Molly Yancovitz United States	8	342 0.7×	312 1.6×	111 0.7×	111 1.6×	90 1.4×	15	601
Benjamin Weide Germany	13	328 0.7×	246 1.2×	164 1.1×	49 0.7×	61 1.0×	25	488
Augustinus P. T. van der Ploeg Netherlands	14	525 1.1×	213 1.1×	99 0.6×	211 3.0×	41 0.6×	15	613
Christy Walker United Kingdom	8	479 1.0×	272 1.4×	77 0.5×	158 2.2×	79 1.2×	11	635
Adi Nosrati United States	13	671 1.5×	210 1.1×	354 2.3×	124 1.7×	49 0.8×	22	911
Geoffrey F. Watson Australia	9	368 0.8×	155 0.8×	65 0.4×	126 1.8×	41 0.6×	11	519
D. Verver Netherlands	12	355 0.8×	148 0.7×	51 0.3×	146 2.1×	34 0.5×	26	479

Countries citing papers authored by Robert V. Rawson

Since Specialization

Citations

This map shows the geographic impact of Robert V. Rawson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert V. Rawson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert V. Rawson more than expected).

Fields of papers citing papers by Robert V. Rawson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert V. Rawson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert V. Rawson. The network helps show where Robert V. Rawson may publish in the future.

Co-authorship network of co-authors of Robert V. Rawson

This figure shows the co-authorship network connecting the top 25 collaborators of Robert V. Rawson. A scholar is included among the top collaborators of Robert V. Rawson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert V. Rawson. Robert V. Rawson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Potter, Alison J., Peter M. Ferguson, Serigne Lo, et al.. (2024). The Prognostic Significance of Tumoral Melanosis. Journal of Cutaneous Pathology. 53(1). 60–70.

Gonzalez, Maria, Alexander Christopher Jonathan Van Akkooi, Sydney Ch’ng, et al.. (2024). A phase 2 study to determine the pathological (path) response to neoadjuvant nivolumab (nivo) and relatlimab (rela) in stage I to III resectable Merkel cell carcinoma (Neo-MCC).. Journal of Clinical Oncology. 42(16_suppl). TPS9613–TPS9613.

Vergara, Ismael A., Robert V. Rawson, Serigne Lo, et al.. (2023). Molecular and clinical correlates of HER3 expression highlights its potential role as a therapeutic target in melanoma. Pathology. 55(5). 629–636. 4 indexed citations

Marsh‐Wakefield, Felix, Robert V. Rawson, Tuba N. Gide, et al.. (2022). Distinct pretreatment innate immune landscape and posttreatment T cell responses underlie immunotherapy-induced colitis. JCI Insight. 7(21). 10 indexed citations

Rawson, Robert V., Alison J. Potter, Elizabeth C. Paver, et al.. (2022). Melanomas in children and adolescents: Clinicopathologic features and survival outcomes. Journal of the American Academy of Dermatology. 88(3). 609–616. 7 indexed citations

Potter, Alison J., Andrew J. Colebatch, Robert V. Rawson, et al.. (2022). Pathologist initiated reflex BRAF mutation testing in metastatic melanoma: experience at a specialist melanoma treatment centre. Pathology. 54(5). 526–532. 1 indexed citations

Reijers, Irene L. M., Robert V. Rawson, Andrew J. Colebatch, et al.. (2022). Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma. JAMA Surgery. 157(4). 335–335. 25 indexed citations

Rawson, Robert V., Serigne Lo, Tasnia Ahmed, et al.. (2022). Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites. Journal for ImmunoTherapy of Cancer. 10(9). e004884–e004884. 32 indexed citations

Antoranz, Asier, Anna Szumera‐Ciećkiewicz, Paweł Teterycz, et al.. (2021). Road to Metastasis: The TWEAK Pathway as a Discriminant between Metastasizing and Non-Metastasizing Thick Melanomas. International Journal of Molecular Sciences. 22(19). 10568–10568. 3 indexed citations

10.

Dessinioti, Clio, Alan C. Geller, David C. Whiteman, et al.. (2021). Not all melanomas are created equal: a review and call for more research into nodular melanoma. British Journal of Dermatology. 185(4). 700–710. 17 indexed citations

11.

Rawson, Robert V., James S. Wilmott, & Richard A. Scolyer. (2021). Mucosal Melanoma. Surgical pathology clinics. 14(2). 293–307. 4 indexed citations

12.

Gallagher, Stuart, Robert V. Rawson, Annabelle Mahar, et al.. (2021). Melanoma with osseous or chondroid differentiation: a report of eight cases including SATB2 expression and mutation analysis. Pathology. 53(7). 830–835. 7 indexed citations

13.

Blank, Christian U., Irene L. M. Reijers, Judith M. Versluis, et al.. (2021). LBA39 Personalized combination of neoadjuvant domatinostat, nivolumab (NIVO) and ipilimumab (IPI) in stage IIIB-D melanoma patients (pts) stratified according to the interferon-gamma signature (IFN-γ sign): The DONIMI study. Annals of Oncology. 32. S1315–S1315. 7 indexed citations

14.

Barnhill, Raymond L., Pieter‐Jan van Dam, Peter Vermeulen, et al.. (2020). Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value. The Journal of Pathology Clinical Research. 6(3). 195–206. 34 indexed citations

15.

Haydu, Lauren E., Serigne Lo, Robert V. Rawson, et al.. (2020). The prognostic significance of microsatellites in cutaneous melanoma. Modern Pathology. 33(7). 1369–1379. 17 indexed citations

16.

Scolyer, Richard A., Robert V. Rawson, Jeffrey E. Gershenwald, Peter M. Ferguson, & Víctor G. Prieto. (2019). Melanoma pathology reporting and staging. Modern Pathology. 33(Suppl 1). 15–24. 70 indexed citations

17.

Scolyer, Richard A., H. Peter Soyer, John W. Kelly, et al.. (2019). Improving diagnostic accuracy for suspicious melanocytic skin lesions: New Australian melanoma clinical practice guidelines stress the importance of clinician/pathologist communication. Australian Journal of General Practice. 48(6). 357–362. 11 indexed citations

18.

Long, Janet C., Deborah Debono, Rachel Williams, et al.. (2018). Using behaviour change and implementation science to address low referral rates in oncology. BMC Health Services Research. 18(1). 904–904. 28 indexed citations

19.

Kakavand, Hojabr, Robert V. Rawson, Gulietta M. Pupo, et al.. (2017). PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors. Clinical Cancer Research. 23(20). 6054–6061. 63 indexed citations

20.

Rawson, Robert V., et al.. (2016). Growth hormone secreting pituitary adenoma with admixed gangliocytoma and ganglioglioma. Journal of Clinical Neuroscience. 31. 202–204. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact